Cargando…

Lipid profile and statin use in critical care setting: implications for kidney outcome

OBJECTIVE: To determine whether pre-hospital statin use is associated with lower renal replacement therapy requirement and/or death during intensive care unit stay. METHODS: Prospective cohort analysis. We analyzed 670 patients consecutively admitted to the intensive care unit of an academic tertiar...

Descripción completa

Detalles Bibliográficos
Autores principales:	Malbouisson, Isabelle, Quinto, Beata Marie, Durão, Marcelino de Souza, Monte, Júlio Cesar Martins, dos Santos, Oscar Fernando Pavão, Narciso, Roberto Camargo, Dalboni, Maria Aparecida, Batista, Marcelo Costa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Instituto Israelita de Ensino e Pesquisa Albert Einstein 2019
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6533078/ https://www.ncbi.nlm.nih.gov/pubmed/31166482 http://dx.doi.org/10.31744/einstein_journal/2019AO4399

Ejemplares similares

Frequency of TGF-β and IFN-γ Genotype as Risk Factors for Acute Kidney Injury and Death in Intensive Care Unit Patients
por: Grabulosa, Caren Cristina, et al.
Publicado: (2014)

Cystatin C at Admission in the Intensive Care Unit Predicts Mortality among Elderly Patients
por: Dalboni, Maria Aparecida, et al.
Publicado: (2013)

Impact of acute kidney injury exposure period among liver transplantation patients
por: Narciso, Roberto Camargo, et al.
Publicado: (2013)

Serum soluble-Fas is a predictor of red blood cell transfusion in critically ill patients
por: Korkes, Ilana Levy, et al.
Publicado: (2013)

The impact of continuous renal replacement therapy on renal outcomes in dialysis-requiring acute kidney injury may be related to the baseline kidney function
por: de Souza Oliveira, Marisa Aparecida, et al.
Publicado: (2017)

Serum soluble-Fas, inflammation and anemia in acute renal failure and critical illness
por: Góes, MA, et al.
Publicado: (2011)

Outcomes from a cohort of patients with acute kidney injury subjected to continuous venovenous hemodiafiltration: The role of negative fluid balance
por: dos Santos, Thais Oliveira Claizoni, et al.
Publicado: (2017)

Modelling kidney outcomes based on MELD eras - impact of MELD score in renal endpoints after liver transplantation
por: Lins, Paulo Ricardo Gessolo, et al.
Publicado: (2022)

Lessons for the clinical nephrologist: vascular access recirculation during continuous renal replacement therapy and regional citrate anticoagulation
por: Scherer, Patricia Faria, et al.
Publicado: (2022)

Acid base variables predict survival early in the course of treatment with continuous venovenous hemodiafiltration
por: Passos, Rogério da Hora, et al.
Publicado: (2018)

Association of IL-6 Polymorphism -174G/C and Metabolic Syndrome in Hypertensive Patients
por: Teixeira, Andrei Alkmim, et al.
Publicado: (2015)

Hypercitratemia is a mortality predictor among patients on continuous venovenous hemodiafiltration and regional citrate anticoagulation
por: dos Santos, Thais Oliveira Claizoni, et al.
Publicado: (2023)

Action of nicotinic acid on the reversion of hypoxic-inflammatory link on 3T3-L1 adipocytes
por: Nakamichi, Renata, et al.
Publicado: (2016)

Apolipoprotein E polymorphism modulation of asymmetric dimethylarginine in hypertensive patients is determined by renal function
por: Marrocos, Mauro Sergio Martins, et al.
Publicado: (2016)

Diversity of Apolipoprotein E genetic polymorphism significance on cardiovascular risk is determined by the presence of Metabolic Syndrome among hypertensive patients
por: Teixeira, Andrei Alkmim, et al.
Publicado: (2014)

Predictors of renal function recovery among patients undergoing renal replacement therapy following orthotopic liver transplantation
por: Andreoli, Maria Claudia Cruz, et al.
Publicado: (2017)

Decreasing Mortality in Severe Sepsis and Septic Shock Patients by Implementing a Sepsis Bundle in a Hospital Setting
por: Shiramizo, Sandra Christina Pereira Lima, et al.
Publicado: (2011)

A program for sustained improvement in preventing ventilator associated pneumonia in an intensive care setting
por: Caserta, Raquel A, et al.
Publicado: (2012)

Effects of customized bicarbonate buffered solutions for continuous renal replacement therapies on polymorphonuclear function and viability
por: Maccariello, E, et al.
Publicado: (2003)

Association of Vitamin D Levels With Kidney Volume in Autosomal Dominant Polycystic Kidney Disease (ADPKD)
por: Vendramini, Larissa Collis, et al.
Publicado: (2019)

Lipid profile and response to statin therapy in patients with hypopituitarism
por: Rissetti, Graziela, et al.
Publicado: (2020)

Cholecalciferol decreases inflammation and improves vitamin D regulatory enzymes in lymphocytes in the uremic environment: A randomized controlled pilot trial
por: Carvalho, José Tarcisio G., et al.
Publicado: (2017)

Comparison of statin plus ezetimibe with double-dose statin on lipid profiles and inflammation markers
por: Wu, Na-Qiong, et al.
Publicado: (2018)

Encephalitozoon cuniculi takes advantage of efferocytosis to evade the immune response
por: Dalboni, Luciane Costa, et al.
Publicado: (2021)

Pleiotropic and Lipid–lowering Effects of Statins in Hypertension
por: Kamberi, Lulzim Selim, et al.
Publicado: (2012)

Effects of Plasma Lipids and Statins on Cognitive Function
por: Li, Rui, et al.
Publicado: (2018)

Lipid-lowering drugs (statins) and peripheral neuropathy
por: Emad, Mohammadreza, et al.
Publicado: (2018)

Investigating the Effects of Statins on Cellular Lipid Metabolism Using a Yeast Expression System
por: Leszczynska, Agata, et al.
Publicado: (2009)

COVID-19 and Thromboinflammation: Is There a Role for Statins?
por: Ferrari, Filipe, et al.
Publicado: (2021)

Health Information System
por: de Souza, Valéria Pinheiro, et al.
Publicado: (2013)

Glycaemic Effects of Non-statin Lipid-Lowering Therapies
por: Collins, Patrick D., et al.
Publicado: (2016)

Statins and the Brain: More than Lipid Lowering Agents?
por: Fracassi, Anna, et al.
Publicado: (2019)

Pleiotropic use of Statins as non-lipid-lowering drugs
por: Zhang, Qijia, et al.
Publicado: (2020)

Statins in the critically ill
por: De Loecker, Isabelle, et al.
Publicado: (2012)

Statin therapy and lipids-lowering supplements – safe and effective treatment of lipids disturbances in children
por: Grabarczyk, Małgorzata, et al.
Publicado: (2022)

Molecular mechanisms of statin intolerance
por: Gluba-Brzozka, Anna, et al.
Publicado: (2016)

Beyond lipid lowering: pleiotropic effects of statins in heart failure
por: Swenne, C. A.
Publicado: (2013)

Blood lipid levels, statin therapy and the risk of intracerebral hemorrhage
por: Ma, Yingxu, et al.
Publicado: (2016)

Statin Therapy Alters Lipid Storage in Diabetic Skeletal Muscle
por: Rebalka, Irena A., et al.
Publicado: (2016)

Lipid Testing and Statin Dosing After Acute Myocardial Infarction
por: Wang, William T., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_m8lrjk21nfcvqigkf6938o927v